Coca-Cola and PepsiCo land bull ratings at Piper Sandler
Piper Sandler dipped into the beverage sector on Tuesday by issuing new Overweight ratings on Coca-Cola (NYSE:KO) and PepsiCo ...
bovnews1h
ALLO Unveiled: The Shocking Truth Behind Allogene Therapeutics Inc’s Latest Stock Movements
Allogene Therapeutics Inc (ALLO) stock saw a modest uptick, ending the day at $2.35 which represents a slight increase of $0.19 or 8.80% from the prior close of $2.16. The stock opened at $2.15 and ...
Piper initiates on soda stocks; Pepsi, Coca-Cola ‘overweight,’ Dr Pepper ‘neutral'
Piper Sandler initiated coverage on soda stocks, rating PepsiCo (NASDAQ:PEP), Coca-Cola (NYSE:KO) “overweight,” and Neutral on Keurig Dr Pepper (NASDAQ:KDP).
Piper Sandler: Mid-Market But Better Indexed To Lax FTC (Rating Upgrade)
Piper Sandler Companies is gaining traction with a recovering market. Find out why PIPR stock is becoming an attractive ...
Fortinet Surges as Piper Sandler Predicts 2025 Cybersecurity Boom: Price Target Soars to $120
One of five strong picks for 2025 listed by Piper Sandler is Fortinet, which got a price target rise to $120 from $100. The ...
Piper Sandler Companies (NYSE:PIPR) Cut to “Neutral” at The Goldman Sachs Group
Piper Sandler Companies (NYSE:PIPR – Get Free Report) was downgraded by equities research analysts at The Goldman Sachs Group from a “buy” rating to a “neutral” rating in a report issued on ...
Kenvue stock still has 'ample room': Piper Sandler
Despite recent share appreciation, Piper Sandler believes there is still significant upside for Kenvue. “Though shares have ...
Fortinet gets rating upgrade, among top picks for 2025 at Piper Sandler
Fortinet's (FTNT) stock rose about 3% premarket on Monday after Piper Sandler upgraded the shares to Overweight from Neutral.
Piper Sandler Issues Pessimistic Forecast for Travelers Companies (NYSE:TRV) Stock Price
Travelers Companies (NYSE:TRV – Get Free Report) had its price objective reduced by investment analysts at Piper Sandler from ...
Nasdaq6d
Biogen downgraded to Neutral from Overweight at Piper Sandler
Piper Sandler downgraded Biogen (BIIB) to Neutral from Overweight with a price target of $138, down from $315, following a transfer of coverage. Biogen remains in transition, as management ...
Albemarle (ALB) Receives a Sell from Piper Sandler
In a report released today, Charles Neivert from Piper Sandler maintained a Sell rating on Albemarle (ALB – Research Report), with a price ...